neutral
5 days agoSudeep Pharma Lists at Strong Premium as Investors React to Heavily Subscribed IPO
Sudeep Pharma delivered a robust stock market debut today, listing at ₹730 on the NSE a 23.1% premium to its issue price of ₹593. The shares later climbed above ₹792 as trading momentum strengthened. The ₹895 crore IPO included ₹95 crore of fresh equity and an ₹800 crore offer for sale from promoter groups. Proceeds will support machinery purchases and general corporate needs.
neutral
5 days agoSudeep Pharma Lists at Strong Premium as Investors React to Heavily Subscribed IPO
Sudeep Pharma delivered a robust stock market debut today, listing at ₹730 on the NSE a 23.1% premium to its issue price of ₹593. The shares later climbed above ₹792 as trading momentum strengthened. The ₹895 crore IPO included ₹95 crore of fresh equity and an ₹800 crore offer for sale from promoter groups. Proceeds will support machinery purchases and general corporate needs.
1 min read
64 words
Sudeep Pharma debuted 23% above its issue price after an IPO subscribed 93.72 times, with strong demand and clear use of proceeds supporting investor interest.
Sudeep Pharma delivered a robust stock market debut today, listing at ₹730 on the NSE a 23.1% premium to its issue price of ₹593. The shares later climbed above ₹792 as trading momentum strengthened. The ₹895 crore IPO included ₹95 crore of fresh equity and an ₹800 crore offer for sale from promoter groups. Proceeds will support machinery purchases and general corporate needs.
Sudeep Pharma delivered a robust stock market debut today, listing at ₹730 on the NSE a 23.1% premium to its issue price of ₹593. The shares later climbed above ₹792 as trading momentum strengthened. The ₹895 crore IPO included ₹95 crore of fresh equity and an ₹800 crore offer for sale from promoter groups. Proceeds will support machinery purchases and general corporate needs.
Nov 28, 2025 • 06:21